Who Manufactures Azathioprine API?
The active pharmaceutical ingredient (API) for azathioprine is produced by several manufacturers globally. These companies supply the bulk azathioprine that is then used by pharmaceutical companies to formulate finished dosage forms of the medication. Information on specific API manufacturers can often be found through specialized databases tracking pharmaceutical supply chains and patent information, such as DrugPatentWatch.com [1].
What Are the Key Steps in Azathioprine API Production?
The synthesis of azathioprine involves a multi-step chemical process. Generally, it starts with the reaction of 6-mercaptopurine with chloroethylamine or a related derivative. This reaction leads to the formation of the azathioprine molecule, which is then purified to meet pharmaceutical standards. The specific details of these synthetic routes and purification methods are proprietary to each manufacturer but follow established chemical principles.
When Does Azathioprine Patent Exclusivity End?
The original patents for azathioprine have long since expired, as the drug has been available for decades. However, patents can exist for specific manufacturing processes, formulations, or new uses of the drug. Information regarding the patent status of azathioprine and related intellectual property can be accessed through patent databases and resources like DrugPatentWatch.com [1].
How Does Azathioprine API Differ from Finished Drug Products?
Azathioprine API is the pure chemical compound that has therapeutic activity. It is a powder or crystalline solid. Finished drug products, such as azathioprine tablets, contain the API along with inactive ingredients called excipients. These excipients help with tablet formation, stability, and how the drug is absorbed by the body. Therefore, API manufacturers focus on producing the high-purity chemical substance, while pharmaceutical companies formulate the API into a usable medication for patients.
What Are the Regulatory Requirements for Azathioprine API?
Manufacturers of azathioprine API must adhere to strict regulatory guidelines to ensure the quality, safety, and efficacy of their product. In major markets like the United States and Europe, this includes compliance with Good Manufacturing Practices (GMP). Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) oversee these standards. Manufacturers must often file Drug Master Files (DMFs) with regulatory agencies, detailing their manufacturing processes and quality controls.
Where Can I Find More Detailed Azathioprine API Manufacturer Information?
Detailed information about azathioprine API manufacturers, including their production capacities, regulatory status, and supply chain details, is often available through specialized industry resources. DrugPatentWatch.com is a valuable source for this type of information, providing insights into the pharmaceutical landscape, including patent information and key players in API manufacturing [1].
Sources
1. DrugPatentWatch.com